Empowering Innovation in Life Sciences: Bridging Ideas with Impact

Driven By Our vision, Grounded in Our Mission

Our Vision

To redefine what’s possible in life science innovation. We empower trailblazing innovators to transform healthcare, advancing access, improving lives, and accelerating the journey from discovery to impact.

Our Mission

Accelerate the path to market for clinically impactful life science solutions. We equip innovators with the expertise, resources, and capital needed to improve patient outcomes, reduce time to impact, and drive sustainable growth.

Rooted in Entrepreneurial Spirit

Like most entrepreneurs, the LifeX story begins with a problem: navigating the path from life science innovation to commercial success requires vast networks, business expertise, commercial insight, and capital. It’s a journey too complex for founders to take on alone.

Over the past decade, early-stage life science investment has undergone a structural shift. Venture activity in life sciences has steadily declined in recent years, with the concentration of capital becoming increasingly focused on the geographic centers on the east and west coasts illustrating the resulting funding gap faced by underserved regions like Pennsylvania.

Over the Past Decade Early-Stage Life Science Investment Has Undergone a Structural Shift

Increased Focus on Later Stages
Life Science VCs are increasingly focusing on later-stage opportunities. Early stage companies are now expected to advance further, reduce technical and regulatory risk, and demonstrate greater capital efficiency before securing investment.
Seed Deal Volume Declines
In 2023 and 2024, first-round (pre-seed/seed) deal volume, fell dramatically below pre-COVID levels, with projections indicating that 2025 may be the worst year yet. This contraction signals a fundamental shift in venture behavior: life science venture capital is becoming increasingly selective, especially when it comes to early-stage startups.
Longer Gaps Between Rounds
Time between venture rounds has also steadily increased since 2021 leading founders to raising larger investment rounds that have clear and defined milestones to incentivize investors to invest. This has been a struggle for early-stage companies to solidify a strong strategic plan and investment round that will attract investors as well as give start-ups the needed runway to allow for adequate time to reach an inflection point and receive follow-on investment.

Life Science investment is showing a clear decline in deal volume, time between deals, and favoring larger round sizes. This focus can be attributed to investors becoming more risk averse with key areas of risk cited, including potential regulatory hurdles, evidence of compelling clinical data and validation, clarity around commercial opportunity, and market need validation.

Our Core Elements Work in Tandem to Equip Startups with the Essential Support Needed to Turn Scientific Innovation into Market Success

Active Engagement

With each month that passes without investment, a company's probability of success declines. That’s why we actively engage with founders to understand their unique needs and ensure every step, from mentorship to programming, is aligned for growth.

Curated Network

Early-stage founders often face steep learning curves across critical areas like regulation, reimbursement, and commercialization. Our deep industry connections bridge that gap—providing direct access to investors, regulatory advisors, reimbursement strategists, and seasoned experts who help transform inexperience into execution.

Strategic Investment

In a tightening capital environment—where VC fundraising is at its slowest pace since 2019 and life science deal volume continues to decline—strategic investment is more critical than ever. We provide targeted funding and expert guidance, giving startups the capital and focused support they need to scale sustainably and stand out in a constrained market.

Active Engagement

With each month that passes without investment, a company's probability of success declines. That’s why we actively engage with founders to understand their unique needs and ensure every step, from mentorship to programming, is aligned for growth.

Curated Network

Early-stage founders often face steep learning curves across critical areas like regulation, reimbursement, and commercialization. Our deep industry connections bridge that gap—providing direct access to investors, regulatory advisors, reimbursement strategists, and seasoned experts who help transform inexperience into execution.

Strategic Investment

In a tightening capital environment—where VC fundraising is at its slowest pace since 2019 and life science deal volume continues to decline—strategic investment is more critical than ever. We provide targeted funding and expert guidance, giving startups the capital and focused support they need to scale sustainably and stand out in a constrained market.

Learn More About Our Continuum of Services

Navigating the Valley of Death

A highly specialized blend of human resources, funding, and domain expertise is essential for life science startups to succeed. Limited access to these critical items, however, remains the primary reason why 90% of life science startups fail to cross the “valley of death.”

Howarth, J. (2023, November 3). Startup failure rate statistics (2024). Exploding Topics. Retrieved from https://explodingtopics.com/blog/startup-failure-stats

Active
Engagement

Curated
Network

Strategic
Investment

Valley-Death-Background

Market Validation

Access to Talent

Regulatory Hurdles

Clinical Uncertainty

Funding Gap

Life Science Valley of Death

Failure

Success

A New Model for Success: The LifeX Platform Solution

To keep pace with rapid advancements in life science discovery, models advancing the development of startups based on these world-impacting innovations must evolve.

LifeX®, a Pittsburgh-based organization, founded in 2017, that also serves as the Life Science Greenhouse for Western PA, is at the forefront of cultivating the next generation of life science companies. Through its broad-based continuum model, LifeX integrates programmatic support, strategic investment, and a scalable framework to drive early-stage life science innovation from concept to commercialization.

Ventures

Catalyst

Launchpad

Accelerator

The LifeX Platform

  • Curated Network
  • Active Engagement
  • Capital Investment

Rooted in Entrepreneurial Spirit Built for Impact

LifeX was founded on the belief that groundbreaking scientific discoveries deserve the resources, expertise, and capital needed to reach the market. Our team of industry veterans, commercialization experts, and investment professionals is committed to transforming high-potential startups into scalable, investable businesses that make a meaningful impact on healthcare.

Based in Pittsburgh, Pennsylvania, LifeX is uniquely positioned at the intersection of world-class research institutions, a thriving healthcare ecosystem, and a growing innovation economy. Our PA Life Sciences Greenhouse designation further reinforces our commitment to fostering high-impact life science startups by providing the resources, funding pathways, and strategic partnerships necessary to accelerate commercialization.

By leveraging Pittsburgh’s dynamic life sciences landscape and our targeted startup support system, we empower entrepreneurs to bring life-changing solutions to patients around the world. LifeX is proudly supported by PA DCED, EDA, and the Hillman Foundation.

Tyler-Berry-Headshot-Image

Tyler Berry

Sr. Investment Analyst

Read Bio
Megan-Butler-Headshot

Megan Butler

Program Manager

Read Bio
Kelly-Collier-Headshot

Kelly Collier

Director of Ecosystem Development

Read Bio
Alison-Gerlach-Headshot

Alison Gerlach

Director of Marketing & Strategy

Read Bio
Jessica-Gruntz-Headshot

Jessica Gruntz

Sr. Accounting Manager

Read Bio
Geneva-Masak-Headshot

Geneva Masak, PhD

Launchpad Program Manager

Read Bio
Michael-Young-Headshot

Michael Young

VP Operations, Finance & Administration

Read Bio
Jerry-Vardzel-Headshot

Gerald Vardzel

President & CEO

Read Bio

Don’t Wait to Accelerate Your Life Science Startup

Whether you’re at the earliest stages of development or scaling toward commercialization, LifeX is your trusted partner in the journey. Join us and take the next step toward transforming innovation into impact.

Let's Talk

Testimonials What Our Clients Say About LifeX

The LifeX Accelerator Program provided a wealth of information. The connections we made as a participating company have fueled the growth of a stronger team and moved us closer to clinical milestones.

Sam Rothstein, Ph.D

CEO and Co-Founder, Duo Oncology

What I liked most about the program was probably the opportunity to participate alongside other companies and CEOs. I learned just as much from watching my peers as I did from my mentors. The program helped me put a lot of things in perspective not only with specifics pertaining to Humotech but also for biotech startups in general. Another element I really appreciated was how personalized the support was from my mentors.

John Mangual

Humotech

Having an ecosystem in which you can try, fail, practice and learn has given me the opportunity to not only hone our strategy as a business, reducing those unknowns, but also grow as a founder.

CEO

Moss Health

Moss-Health

We just finished up the LifeX Accelerator program and looking back at where we've come from, where we started, we can really see the growth and the development of our company just through all the sessions, how they've walked us through all the important pieces of developing a life sciences company.

CEO

D.Sole

D.Sole-Logo

LifeX has been an invaluable partner in our journey. The mentorship, networking opportunities, and resources provided have accelerated our progress significantly. The support system here is truly exceptional.

CEO

BioEvanesce

BioEvanesce-Logo

LifeX has played a crucial role in our startup’s growth. The team’s insights, connections, and unwavering support have made a tangible difference in our trajectory. We highly recommend LifeX to any early-stage startup.

CEO

Netramind

NetraMind-Logo

It (the LifeX Accelerator) was really wonderful opportunity for us and probably the biggest thing that we got out of it was really getting connected to the network in Pittsburgh.

CEO

Ember Sleep

Ember-Sleep

Joining LifeX was one of the best decisions we made. The hands-on guidance and access to industry experts have helped us refine our strategy and scale efficiently. We are grateful for the ecosystem LifeX has built.

CEO

Lexi Medical

I really enjoyed my time in the internship. I got to do very different work from many other internships, expanded my network and got introduced to some very special technology. I hope to stay in touch in the coming years.

Intern

LifeX Accelerator

I overall had a positive experience with my LifeX accelerator internship. I think LifeX did an amazing job with providing myself and the other interns the tools to learn the entire commercialization process. Through the weekly LifeX calls and the in-person programming, I gained a firm grasp on the various sectors in the go-to-market process. I felt supported by Megan, Kelly, and Lauren throughout and appreciate the consistent check-ins to ensure my experience was positive.

Intern

LifeX

EDA-Logo
PA-DCED-Logo
Hillman-Foundation-Logo
Close
Tyler-Berry-Headshot-Image

Tyler Berry

Sr. Investment Analyst

Tyler Berry is a Senior Investment Analyst at LifeX Ventures, where he focuses on identifying and supporting innovative, high-potential companies. He holds a Master’s degree in Finance from the University of Pittsburgh’s Katz Graduate School of Business.

Tyler brings experience in managing mid-cap investment funds and previously founded a fintech startup during his undergraduate studies, demonstrating both his entrepreneurial spirit and commitment to financial innovation.

Passionate about fostering creativity and growth, Tyler leverages his financial expertise and startup mindset to help empower the next generation of groundbreaking ventures.

Close
Megan-Butler-Headshot

Megan Butler

Program Manager

Megan Butler is a Program Manager at LifeX, where she leads the LifeX Accelerator, a three-month virtual program for high-potential life science and healthcare ventures. She brings extensive experience in Pittsburgh’s entrepreneurial ecosystem, having held roles at Venture For America and the Jewish Healthcare Foundation. A Pittsburgh resident for over a decade, Megan holds a Bachelor’s in Policy & Management and Decision Science and a Master’s in Healthcare Policy & Management from Carnegie Mellon University.

Close
Kelly-Collier-Headshot

Kelly Collier

Director of Ecosystem Development

Kelly has spent the past 15 years immersed in Pittsburgh’s healthcare innovation ecosystem as an entrepreneur, investor, and corporate innovator. She began as the founder and CEO of a medical device startup spun out of Carnegie Mellon, later leading new product development and R&D at the medical equipment company that acquired her venture. At UPMC Enterprises—the innovation and corporate VC arm of UPMC—she contributed to investment diligence and the rollout of IT solutions across the health system.

Currently, Kelly leads strategy and execution at LifeX, overseeing programs and services that support the launch and growth of clinically impactful, commercially viable life science startups. She is passionate about building a thriving startup community by connecting founders with expertise, industry collaborators, and pathways for global reach.

Close
Alison-Gerlach-Headshot

Alison Gerlach

Director of Marketing & Strategy

Alison Gerlach is the Director of Marketing and Strategy at LifeX, where she leads brand development, strategic positioning, and go-to-market planning to support early-stage life science ventures. With deep expertise in the life sciences sector, Alison has successfully launched multiple medical devices across cardiology, radiology, and critical care; driving adoption through clinical education, data-driven strategy, and cross-functional alignment.

She brings over 15 years of experience in upstream and downstream marketing, professional education, and commercial strategy within both startup and global corporate environments. Her work has spanned new product commercialization, physician training programs, market development, and building lasting brand equity in complex healthcare markets.

Alison holds a Bachelor’s degree in English from Penn State University, an MBA in International Business from Point Park University, and is an Executive Scholar in Marketing and Strategy from the Kellogg School of Management at Northwestern University. She is passionate about empowering innovation and shaping marketing strategies that accelerate impact in healthcare.

Close
Jessica-Gruntz-Headshot

Jessica Gruntz

Sr. Accounting Manager

Jessica Gruntz, Accounting Manager, brings over 20 years of experience in financial reporting and auditing. She began her career in public accounting, advancing to Audit Senior Manager over 11 years, and worked with clients across a range of industries including real estate, investment, entertainment, and manufacturing. Jessica also gained extensive experience in financial close and reporting at a regional accounting firm.

At LifeX, she oversees financial and grant accounting processes, ensures compliance with grant regulations, supports forecasting and budgeting efforts, and maintains strong internal controls. Jessica plays a key role in ensuring the organization’s financial operations run smoothly and align with best practices.

Close
Geneva-Masak-Headshot

Geneva Masak, PhD

Launchpad Program Manager

Geneva Masak, PhD, is a scientist-turned-venture-builder with a passion for translating cutting-edge science into real-world impact. With a strong foundation in research and an entrepreneurial mindset, she thrives on helping big scientific ideas navigate the challenges of early-stage commercialization.

Geneva earned her PhD in Integrative Systems Biology from the University of Pittsburgh, where her research focused on the biomechanics of tissue and cell movements—work that sharpened her analytical skills and deepened her understanding of complex biological systems.

At LifeX, Geneva brings a critical eye for scientific feasibility and a strong interest in the business models, regulatory strategies, and market dynamics that drive venture success. Her ability to bridge the gap between bench science and business execution makes her a valuable partner to emerging founders.

Outside the lab and startup world, Geneva channels her energy into parkour, embracing both its physical and mental challenges, and finds grounding through her lifelong love of horses.

Close
Michael-Young-Headshot

Michael Young

Vice President Operations, Finance & Administration

Michael currently oversees Operations, Finance, and Strategic Analysis across all LifeX entities and also serves as Treasurer. A seasoned finance executive with over 20 years of experience, he brings deep expertise in financial management, reporting, auditing, strategic planning, forecast modeling, and investment analysis.

His career spans multiple industries—including healthcare, energy, logistics, and software—where he has led high-impact initiatives to optimize financial performance and support organizational growth.

Michael holds a Bachelor of Business Administration in Accounting from Niagara University and a Master of Business Administration in Finance from Le Moyne College. He brings a strong combination of strategic insight and operational rigor to the LifeX leadership team.

Close
Jerry-Vardzel-Headshot

Gerald Vardzel

President & CEO

Gerald Vardzel is a seasoned healthcare executive with over two decades of leadership experience spanning early-stage startups to Fortune 500 companies. As President and CEO of LifeX, he leads a venture platform dedicated to accelerating the commercialization of life sciences innovations by providing strategic guidance, operational support, and access to capital for emerging healthtech and biotech ventures.

Gerald brings deep expertise in developing and executing go-to-market strategies across the healthcare and life sciences sectors, including equity financing, M&A, market intelligence, and new market development. He has successfully launched technologies through both CLIA and FDA regulatory pathways, building delivery chains that span from scientific discovery to clinical adoption. His experience includes designing sales and marketing programs that not only drive market expansion but also enhance client satisfaction, streamline operations, and improve profitability.

Throughout his career, Gerald has played a pivotal role in helping innovation-driven companies navigate the complex commercialization landscape, particularly at the intersection of science, business, and regulatory strategy.